Validation of hemoglobin glycation models using glycemia monitoring in vivo and culturing of erythrocytes in vitro

Annals of Biomedical Engineering

Volumn 36, Issue 7, 2008, Pages 1188-1202

  Ładyżyński, Piotr ^a   Wójcicki, Jan M ^a   Bąk, Marianna ^b   Sabalińska, Stanisława ^a   Kawiak, Jerzy ^a   Foltyński, Piotr ^a   Krzymień, Janusz ^b   Karnafel, Waldemar ^b  

^a INSTITUTE OF BIOCYBERNETICS AND BIOMEDICAL ENGINEERING   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Diabetes mellitus; Glycemic control; HbA1c; Mathematical modeling; Metabolic control

Indexed keywords

BLOOD; CONCENTRATION (PROCESS); GLUCOSE; MATHEMATICAL MODELS;

DIABETES MELLITUS; METABOLIC CONTROL;

CELL CULTURE;

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; BIOLOGICAL MODEL; BLOOD; BLOOD ANALYSIS; CELL CULTURE; COMPUTER ASSISTED DIAGNOSIS; COMPUTER SIMULATION; DIABETES MELLITUS; ERYTHROCYTE; EVALUATION; FEMALE; GLYCEMIC INDEX; HUMAN; MALE; METABOLISM; METHODOLOGY; MONITORING; PATHOLOGY; VALIDATION STUDY;

ADULT; BLOOD CHEMICAL ANALYSIS; CELLS, CULTURED; COMPUTER SIMULATION; DIABETES MELLITUS; DIAGNOSIS, COMPUTER-ASSISTED; ERYTHROCYTES; FEMALE; GLYCEMIC INDEX; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MODELS, CARDIOVASCULAR; MONITORING, PHYSIOLOGIC;

EID: 44649132650     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-008-9508-x     Document Type: Article

References (28)

1. American Diabetes Association. Tests of glycemia in diabetes. Diabetes Care 25:S97-99, 2002. doi: 10.2337/diacare.25.2007.S97
2. Bastanhagh M. H., A. R. Shirvan, R. Heshmat, A. Khalilifard, A. Keshtkar, B. Larijan. Evaluation of the effi cacy of blood glucose home monitoring devices. Med. Sci. Monit. 13:PI1-6, 2007
3. Beach K. W. A theoretical model to predict the behavior of glycosylated hemoglobin levels. J. Theor. Biol. 81:547-561, 1979. doi: 10.1016/0022-5193(79) 90052-3
4. Bunn H. F., D. N. Haney, K. H. Gabbay, P. M. Gallop. Further identification of the nature and linkage of the carbohydrate in hemoglobin A1c. Biochem. Biophys. Res. Commun. 67:103-109, 1975. doi: 10.1016/0006-291X(75) 90289-2
5. College of American Pathologists. The College of American Pathologists fresh sample proficiency testing survey for A1c. http://www.ngsp.org/prog/CAP/ CAP07a.pdf, 2007
6. Consensus Committee. Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine and the International Diabetes Federation. Diabetes Care. 30:2399-2400, 2007. doi: 10.2337/dc07-9925
7. Delpierre G., D. Vertommen, D. Communi, M. H. Rider, E. Van Schaftingen. Identification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin. J. Biol. Chem. 279:27613-27620, 2004. doi: 10.1074/jbc.M402091200
8. Diabetes in Research Children Network (DirecNet) Study Group. Evaluation of factors affecting CGMS calibration. Diabetes Technol. Ther. 8:318-325, 2006. doi: 10.1089/dia.2006.8.318
9. Fogh-Andersen N., P. D'Orazio. Proposal for standardizing direct-reading biosensors for blood glucose. Clin. Chem. 44:655-659, 1998
10. Graf R., J. Halter, D. Porte Jr. Glycosylated hemoglobin in normal subjects and subjects with maturity-onset diabetes. Evidence for a saturable system in man. Diabetes. 27:834-839, 1978. doi: 10.2337/diabetes.27.8.834
11. Guerci B., M. Floriot, P. Böhme, D. Durain, M. Benichou, S. Jellimann, P. Drouin. Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs. Diabetes Care. 26:582-589, 2003. doi: 10.2337/diacare.26.3.582
12. Higgins P. J., H. F. Bunn. Kinetic analysis of the nonenzymatic glycosylation of hemoglobin. J. Biol. Chem. 256:5204-5208, 1981
13. Hoelzel W., C. Weykamp, J. O. Jeppsson, K. Miedema, J. R. Barr, I. Goodall, T. Hoshino, W. G. John, U. Kobold, R. Little, A. Mosca, P. Mauri, R. Paroni, F. Susanto, I. Takei, L. Thienpont, M. Umemoto, H. M. Wiedmeyer. IFCC Working Group on HbA1c Standardization. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin. Chem. 50:166-174, 2004. doi: 10.1373/clinchem.2003.024802
14. Jeffcoate S. L. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet. Med. 21:657-665, 2004. doi: 10.1046/j.1464-5491.2003.01065.x
15. Jeppsson J. O., U. Kobold, J. Barr, A. Finke, W. Hoelzel, T. Hoshino, K. Miedema, A. Mosca, P. Mauri, R. Paroni, L. Thienpont, M. Umemoto, C. Weykamp. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC): Approved IFCC reference method for the measurement of HbA1c in human blood. Clin. Chem. Lab. Med. 40:78-89, 2002. doi: 10.1515/CCLM.2002.016
16. YSI Life Sciences, YSI 2300 Stat Plus-Operation Manual. Yellow Springs: YSI Inc., 7 pp, 2003
17. Mortensen H. B., C. Christophersen. Glucosylation of human haemoglobin A in red blood cells studied in vitro. Kinetics of the formation and dissociation of haemoglobin A1c. Clin. Chim. Acta. 134:317-326, 1983. doi: 10.1016/0009-8981(83)90370-4
18. Mortensen H. B., A. Vølund. Variations in hemoglobin A1c and blood glucose in children with newly diagnosed diabetes mellitus described by a biokinetic model. Diabetes Metab. 10:18-24, 1984
19. Mortensen H. B., A. Vølund. Application of a biokinetic model for prediction and assessment of glycated haemoglobins in diabetic patients. Scand. J. Clin. Lab. Invest. 48:595-602, 1988. doi: 10.3109/00365518809085778
20. Osterman-Golkar S. M., H. W. Vesper. Assessment of the relationship between glucose and A1c using kinetic modeling. J. Diabetes Complicat. 20:285-294, 2006. doi: 10.1016/j.jdiacomp.2005.07.009
21. Skowroska M., B. Marczewska. The comparative study of glucose determination by selected point-of-care glucose meters on the quality control viewpoint. Diebetologia Praktyczna 6:173-176, 2005
22. Smith R. J., R. J. Koenig, A. Binnerts, J. S. Soeldner, T. T. Aoki. Regulation of hemoglobin A1c formation in human erythrocytes in vitro. Effects of physiologic factors other than glucose. J. Clin. Invest. 69:1164-1168, 1982. doi: 10.1172/JCI110552
23. Tahara Y., K. Shima. The response of GHb to stepwise plasma glucose change over time in diabetic patients. Diabetes Care. 16:1313-1314, 1993
24. Tosi F., M. Muggeo, E. Brun, G. Spiazzi, L. Perobelli, E. Zanolin, M. Gori, A. Coppini, P. Moghetti. Combination treatment with metformin and glibenclamide versus single-drug therapies in type 2 diabetes mellitus: a randomized, double-blind, comparative study. Metabolism. 52:862-867, 2003. doi: 10.1016/S0026-0495(03)00101-X
25. Traczyk W. Z., A. Trzebski (eds.). Human Physiology with Elements of the Applied and Clinical Physiology. Warszawa: PZWL, 2004, 210 pp
26. Vermes I., C. Haanen, H. Steffens-Nakken, C. Reutelingsperger. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Meth. 184:39-51, 1995. doi: 10.1016/0022-1759(95)00072-I
27. Willekens F. L., B. Roerdinkholder-Stoelwinder, Y. A. Groenen-Döpp, H. J. Bos, G. J. Bosman, A. G. van den Bos, A. J. Verkleij, J. M. Werre. Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation. Blood 101:747-751, 2003. doi: 10.1182/blood-2002-02-0500
28. Zhang Y., S. Neelamegham. "Cell counter, blood." In: Encyclopedia of Medical Devices and Instrumentation, edited by J. G. Webster. New York: John Wiley & Sons, 2006